Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer
Integrated Analysis of Multi-center Cohorts and Bulk RNA-sequencing Data Reveal Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer
1 other identifier
observational
15,244
0 countries
N/A
Brief Summary
The clinical and pathological features of early-onset colorectal cancer (EOCRC) differ from those of late-onset colorectal cancer (LOCRC). Our research aims to thoroughly elucidate the distinctions between them by analyzing clinical prognosis, metastatic patterns, gene expression, and genomic mutation profiles. Our deliberation will uncover latent strategies for personalized therapeutic of both EOCRC and LOCRC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2008
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedFirst Submitted
Initial submission to the registry
September 11, 2023
CompletedFirst Posted
Study publicly available on registry
September 15, 2023
CompletedSeptember 15, 2023
September 1, 2023
11 years
September 11, 2023
September 11, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
OS
overall survival
5 years after intervention
Study Arms (3)
EOCRC
Patients aged\<50 with colorectal cancer between 2008 and 2018 in Fudan university Shanghai cancer center.
IOCRC
Patients aged between 50 to 70 with colorectal cancer between 2008 and 2018 in Fudan university Shanghai cancer center.
LOCRC
Patients aged between≥70 with colorectal cancer between 2008 and 2018 in Fudan university Shanghai cancer center.
Interventions
Patients enrolled in these 2 cohorts all received standardized treatment of colorectal cancer.
Eligibility Criteria
Patients with colorectal cancer hospitalized in Fudan university Shanghai cancer center.
You may qualify if:
- The initial diagnosis of colonoscopy and pathology belongs to colorectal cancer;
- Patients should sign an informed consent form after fully understanding the purpose, procedures and potential risks of the study, indicating their voluntary participation in the research.
You may not qualify if:
- Patients with obvious local or systemic severe infection;
- Acute abdomen: intestinal obstruction, peritonitis, intestinal perforation;
- Have a systemic underlying disease that has not been controlled, or is unstable;
- Patients with poor physical fitness or serious other organic diseases who cannot tolerate anesthesia and surgery;
- Women during pregnancy, perinatal and lactation;
- Patients with severe mental disorders (such as schizophrenia, bipolar disorder, etc.) or patients who are mentally incapable or unable to understand the requirements for participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 11, 2023
First Posted
September 15, 2023
Study Start
January 1, 2008
Primary Completion
December 31, 2018
Study Completion
June 30, 2023
Last Updated
September 15, 2023
Record last verified: 2023-09